UPDATE: Zenodo migration postponed to Oct 13 from 06:00-08:00 UTC. Read the announcement.

Journal article Open Access

Tetramer-Based Enrichment of Preexisting Anti-AAV8 CD8+ T Cells in Human Donors Allows the Detection of a TEMRA Subpopulation

Vandamme Céline; Xicluna Rebecca; Hesnard Leslie; Devaux Marie; Jaulin Nicolas; Guilbaud Mickaël; Le Duff Johanne; Couzinié Célia; Moullier Philippe; Saulquin Xavier; Adjali Oumeya


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <controlfield tag="005">20211020134914.0</controlfield>
  <controlfield tag="001">5584580</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France</subfield>
    <subfield code="a">Xicluna Rebecca</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France</subfield>
    <subfield code="a">Hesnard Leslie</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France</subfield>
    <subfield code="a">Devaux Marie</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France</subfield>
    <subfield code="a">Jaulin Nicolas</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France</subfield>
    <subfield code="a">Guilbaud Mickaël</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France</subfield>
    <subfield code="a">Le Duff Johanne</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France</subfield>
    <subfield code="a">Couzinié Célia</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France</subfield>
    <subfield code="a">Moullier Philippe</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, Nantes, France</subfield>
    <subfield code="a">Saulquin Xavier</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France</subfield>
    <subfield code="a">Adjali Oumeya</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">1680892</subfield>
    <subfield code="z">md5:680c15efb966d79efd3a6d5b4ee91cf7</subfield>
    <subfield code="u">https://zenodo.org/record/5584580/files/Vandamme et al 2020.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2021-01-20</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="p">user-upgrade-h2020-project</subfield>
    <subfield code="o">oai:zenodo.org:5584580</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="p">Frontiers in Immunology</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">INSERM UMR 1089, Université de Nantes, CHU de Nantes, Nantes, France</subfield>
    <subfield code="a">Vandamme Céline</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Tetramer-Based Enrichment of Preexisting Anti-AAV8 CD8+ T Cells in Human Donors Allows the Detection of a TEMRA Subpopulation</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-upgrade-h2020-project</subfield>
  </datafield>
  <datafield tag="536" ind1=" " ind2=" ">
    <subfield code="c">825825</subfield>
    <subfield code="a">Unlocking Precision Gene Therapy</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;&lt;strong&gt;Abstract&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Pre-existing immunity to AAV capsid may compromise the safety and efficiency of rAAV-mediated gene transfer in patients. Anti-capsid cytotoxic immune responses have proven to be a challenge to characterize because of the scarcity of circulating AAV-specific CD8+&amp;nbsp;T lymphocytes which can seldom be detected with conventional flow cytometry or ELISpot assays. Here, we used fluorescent MHC class I tetramers combined with magnetic enrichment to detect and phenotype AAV8-specific CD8+&amp;nbsp;T cells in human PBMCs without prior amplification. We showed that all healthy individuals tested carried a pool of AAV8-specific CD8+&amp;nbsp;T cells with a CD45RA+CCR7&amp;minus;&amp;nbsp;terminally-differentiated effector memory cell (TEMRA) fraction.&amp;nbsp;&lt;em&gt;Ex vivo&lt;/em&gt;&amp;nbsp;frequencies of total AAV-specific CD8+&amp;nbsp;T cells were not predictive of IFN&amp;gamma; ELISpot responses but interestingly we evidenced a correlation between the proportion of TEMRA&amp;nbsp;cells and IFN&amp;gamma; ELISpot positive responses. TEMRA&amp;nbsp;cells may then play a role in recombinant AAV-mediated cytotoxicity in patients with preexisting immunity. Overall, our results encourage the development of new methods combining increased detection sensitivity of AAV-specific T cells and their poly-functional assessment to better characterize and monitor AAV capsid-specific cellular immune responses in the perspective of rAAV-mediated clinical trials.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.3389/fimmu.2019.03110</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>
42
28
views
downloads
Views 42
Downloads 28
Data volume 47.1 MB
Unique views 42
Unique downloads 27

Share

Cite as